Brighter receives SEK 21.7 million from exercise of TO4 warrants

The final exercise period for Brighter’s TO4 warrants is now completed. The company receives SEK 21.7 million and the number of shares increases by 10,867,670, to a total of 209,904,250 shares. With this, Brighter TO4 warrants ceases to exist.

Those who participated in this exercise period have obtained interim shares. Once the registration has been completed with the Swedish Companies Registration Office, conversion of the interim shares will automatically take place without further notice to the holders.

For further information, please contact:

Ann Zetterberg, CFO
+46 708 37 21 23
ann.zetterberg@brighter.se

Certified Adviser
Brighter’s Certified Adviser is Eminova Fondkommission AB, +46 (0)8 – 684 211 10, adviser@eminova.se, www.eminova.se.

About Brighter AB (publ)
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to provide smarter care for chronic conditions. Our daily-care solutions facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – improving quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. The Company's shares are listed on Nasdaq First North Growth Market/BRIG.

This information is information that Brighter AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 16:32 CET on September 15, 2020.